Prognostic factors among elderly patients with operable non-metastatic breast cancer treated with primary endocrine therapy

被引：0
|
作者：
Rocha, Erika Andrade
Vasconcellos, Jessica Monteiro
Mendes, Sofia Vidaurre
Freire, Pedro Jose Galvao
Messias, Ana Paula
Leis, Leticia Vecchi
Moreira, Otavio Noschang
Pereira, Mauricio Baptista
Orsi, Bruna Zanin
Araujo Neto, Augusto
Petry, Vanessa
Bonadio, Renata Colombo
Testa, Laura
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P4-07-32
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-07-32
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The long term outcomes of female patients treated with primary endocrine therapy for non-metastatic breast cancer
    Morrow, E.
    Griffard, A.
    Murray, J.
    Lannigan, A.
    CANCER RESEARCH, 2017, 77
  • [2] A study of the long term outcomes of patients treated with primary endocrine therapy for non-metastatic breast cancer.
    Morrow, E. S.
    Griffard, A.
    Murray, J.
    BRITISH JOURNAL OF SURGERY, 2016, 103 : 139 - 140
  • [3] Outcomes of Older Patients with Non-Metastatic Breast Cancer Treated with Primary Hormonal Therapy
    Koh, S. W.
    Morrogh, M.
    Corrigan, M.
    Kelly, L.
    O'Sullivan, M. J.
    Quinn, E. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 : S208 - S208
  • [4] Concurrent factors associated with adherence to adjuvant endocrine therapy among women with non-metastatic breast cancer
    Walsh, Emily A.
    Walsh, Leah E.
    Hernand, Max
    Horick, Nora
    Antoni, Michael H.
    Temel, Jennifer S.
    Greer, Joseph A.
    Jacobs, Jamie M.
    JOURNAL OF CANCER SURVIVORSHIP, 2024,
  • [5] Low incidence of distant metastases in older women with non-metastatic breast cancer treated with primary endocrine therapy
    Kostev, Karel
    Kalder, Matthias
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (01) : 181 - 182
  • [6] Low incidence of distant metastases in older women with non-metastatic breast cancer treated with primary endocrine therapy
    Karel Kostev
    Matthias Kalder
    Breast Cancer Research and Treatment, 2024, 203 : 181 - 182
  • [7] Factors associated with adjuvant endocrine therapy adherence in non-metastatic breast cancer.
    Neuner, Joan Marie
    Winn, Aaron N.
    Pezzin, Liliana E.
    Laud, Purushottam W.
    Nattinger, Ann B.
    Fergestrom, Nicole
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women
    Morgan, Jenna
    Wyld, Lynda
    Collins, Karen A.
    Reed, Malcolm W.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (05):
  • [9] CONFIRMATION OF A PROGNOSTIC INDEX FOR PATIENTS WITH METASTATIC BREAST-CANCER TREATED BY ENDOCRINE THERAPY
    ROBERTSON, JFR
    DIXON, AR
    NICHOLSON, RI
    ELLIS, IO
    ELSTON, CW
    BLAMEY, RW
    BREAST CANCER RESEARCH AND TREATMENT, 1992, 22 (03) : 221 - 227
  • [10] Anastrozole compared to tamoxifen as primary endocrine therapy for early operable primary breast cancer in the elderly
    Ying, M.
    Agrawal, A.
    Winterbottom, L.
    Morgan, D. A.
    Ellis, I. O.
    Cheung, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345